Invasive Cutaneous Mucormycosis in a Patient With Chronic Lymphocytic Leukemia on Obinutuzumab, Idelalisib, and Bruton Tyrosine Kinase Degrader: A Case Report

By afschroeder • October 24, 2025

Morinishi CD, Brown CE, Younes R. Invasive Cutaneous Mucormycosis in a Patient With Chronic Lymphocytic Leukemia on Obinutuzumab, Idelalisib, and Bruton Tyrosine Kinase Degrader: A Case Report. Cureus. 2025 Sep 22;17(9):e92967. doi: 10.7759/cureus.92967. PMID: 41133038; PMCID: PMC12543441.

Tags: Biologics, bruton tyrosine kinase degrader, cutaneous mucorales, idelalisib, immunocompromised, Infectious Diseases, invasive fungal infection, obinutuzumab, Publications

The association between cannabis use and electrocardiographic abnormalities in people living with HIV

Larson ME, Pan Y, Lakhani F, Chavez J, Santana A, Nogueira NF, Lieberman A, Riley ED, Wu KC, Tien P, Kizer J, Floris-Moore M, Pyslar[...]

Association between postdischarge antibiotic use and C. difficile testing as a surrogate for clinically significant diarrhea

Livorsi DJ, Merchant J, Cho H, Goetz MB, Alexander B, Goto M. Association between postdischarge antibiotic use and C. difficile testing as a surrogate for clinically significant[...]

Field evaluation of a dual treponemal/non-treponemal point-of-care test for syphilis within an HIV pre-exposure prophylaxis programme in Hanoi, Vietnam

Biba U, Bui HTM, Nguyen LT, Dang HT, Bui TT, Nguyen TC, Dau NS, Pham LQ, Giang LM, Adamson PC. Field evaluation of a dual[...]